Entrada Therapeutics, Inc. (TRDA)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Endosomal Escape Vehicle Therapeutics	210.78M	Log In
Endosomal Escape Vehicle Therapeutics Growth	63.38%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
United States	210.78M	Log In
United States Growth	63.38%	Log In